• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过外显子组测序诊断为脯氨酰肽酶缺乏症的患者中鉴定出的PEPD基因新复合杂合变异体的结构分析。

Structural analysis of new compound heterozygous variants in PEPD gene identified in a patient with Prolidase Deficiency diagnosed by exome sequencing.

作者信息

Linhares Natália D, Wilk Piotr, Wątor Elżbieta, Tostes Meire A, Weiss Manfred S, Pena Sergio D J

机构信息

Universidade Federal de Minas Gerais, Faculdade de Medicina, Laboratório de Genômica Clínica, Belo Horizonte, MG, Brazil.

Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, Departamento de Bioquímica e Imunologia, Belo Horizonte, MG, Brazil.

出版信息

Genet Mol Biol. 2021 Apr 19;44(2):e20200393. doi: 10.1590/1678-4685-GMB-2020-0393. eCollection 2021.

DOI:10.1590/1678-4685-GMB-2020-0393
PMID:33877262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8056889/
Abstract

Prolidase Deficiency (PD) is an autosomal recessive rare disorder caused by loss or reduction of prolidase enzymatic activity due to variants in the PEPD gene. PD clinical features vary among affected individuals: skin ulcerations, recurrent infections, and developmental delay are common. In this study, we describe a 16-year-old boy with a mild PD phenotype comprising chronic eczema, recurrent infections and elevated IgE. Whole exome sequencing analysis revealed three PEPD variants: c.575T>C p.(Leu192Pro) inherited from the mother, and c.692_694del p.(Tyr231del) and c.1409G>A p.(Arg470His), both inherited from the father. The variant p.(Tyr231del) has been previously characterized by high-resolution X-ray structure analysis as altering protein dynamics/flexibility. In order to study the effects of the other two prolidase variants, we performed site directed mutagenesis purification and crystallization studies. A high-resolution X-ray structure could only be obtained for the p.(Arg470His) variant, which showed no significant structural differences in comparison to WT prolidase. On the other hand, the p.(Leu192Pro) variant led to significant protein destabilization. Hence, we conclude that the maternal p.(Leu192Pro) variant was likely causally associated with the proband´s disease, together with the known pathogenic paternal variant p.(Tyr231del). Our results demonstrated the utility of exome sequencing to perform diagnosis in PD cases with mild phenotype.

摘要

脯氨酰二肽酶缺乏症(PD)是一种常染色体隐性罕见疾病,由PEPD基因变异导致脯氨酰二肽酶活性丧失或降低引起。PD的临床特征在受影响个体中各不相同:皮肤溃疡、反复感染和发育迟缓很常见。在本研究中,我们描述了一名16岁男孩,具有轻度PD表型,包括慢性湿疹、反复感染和IgE升高。全外显子组测序分析揭示了三个PEPD变异:从母亲遗传的c.575T>C p.(Leu192Pro),以及从父亲遗传的c.692_694del p.(Tyr231del)和c.1409G>A p.(Arg470His)。变异p.(Tyr231del)先前已通过高分辨率X射线结构分析表征为改变蛋白质动力学/灵活性。为了研究其他两个脯氨酰二肽酶变异的影响,我们进行了定点诱变、纯化和结晶研究。仅获得了p.(Arg470His)变异的高分辨率X射线结构,与野生型脯氨酰二肽酶相比,该结构没有显著的结构差异。另一方面,p.(Leu192Pro)变异导致蛋白质显著不稳定。因此,我们得出结论,母亲的p.(Leu192Pro)变异可能与先证者的疾病有因果关系,同时还有已知的致病父亲变异p.(Tyr231del)。我们的结果证明了外显子组测序在诊断轻度表型PD病例中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/2a20897a2c61/1415-4757-GMB-44-2-e20200393-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/52c670b0a0bc/1415-4757-GMB-44-2-e20200393-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/cff6a565db9f/1415-4757-GMB-44-2-e20200393-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/1fc7c837884f/1415-4757-GMB-44-2-e20200393-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/775edba771ef/1415-4757-GMB-44-2-e20200393-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/463b88325446/1415-4757-GMB-44-2-e20200393-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/0e05df949e46/1415-4757-GMB-44-2-e20200393-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/2a20897a2c61/1415-4757-GMB-44-2-e20200393-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/52c670b0a0bc/1415-4757-GMB-44-2-e20200393-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/cff6a565db9f/1415-4757-GMB-44-2-e20200393-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/1fc7c837884f/1415-4757-GMB-44-2-e20200393-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/775edba771ef/1415-4757-GMB-44-2-e20200393-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/463b88325446/1415-4757-GMB-44-2-e20200393-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/0e05df949e46/1415-4757-GMB-44-2-e20200393-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f90/8056889/2a20897a2c61/1415-4757-GMB-44-2-e20200393-gf7.jpg

相似文献

1
Structural analysis of new compound heterozygous variants in PEPD gene identified in a patient with Prolidase Deficiency diagnosed by exome sequencing.通过外显子组测序诊断为脯氨酰肽酶缺乏症的患者中鉴定出的PEPD基因新复合杂合变异体的结构分析。
Genet Mol Biol. 2021 Apr 19;44(2):e20200393. doi: 10.1590/1678-4685-GMB-2020-0393. eCollection 2021.
2
Further Clinical Delineation of Prolidase Deficiency Associated with c.1103T>G Variant.与c.1103T>G变异相关的脯氨酰肽酶缺乏症的进一步临床描述
Mol Syndromol. 2024 Aug;15(4):289-296. doi: 10.1159/000536434. Epub 2024 Feb 16.
3
Expanding the clinical and immunological phenotype of prolidase deficiency: A case report.扩展脯氨酰肽酶缺乏症的临床和免疫学表型:病例报告。
Pediatr Dermatol. 2024 Jan-Feb;41(1):115-118. doi: 10.1111/pde.15413. Epub 2023 Aug 13.
4
Structural basis for prolidase deficiency disease mechanisms.脯肽酶缺乏症发病机制的结构基础。
FEBS J. 2018 Sep;285(18):3422-3441. doi: 10.1111/febs.14620. Epub 2018 Aug 14.
5
Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in .利妥昔单抗治疗原发性脯氨酰肽酶缺乏症:一种新的致病性拷贝数变异。
RMD Open. 2023 Dec 7;9(4):e003507. doi: 10.1136/rmdopen-2023-003507.
6
Prolidase deficiency: A novel PEPD missense variant in exon 2.脯氨酰二肽酶缺乏症:外显子2中的一种新型PEPD错义变异体。
Am J Med Genet A. 2023 May;191(5):1388-1394. doi: 10.1002/ajmg.a.63137. Epub 2023 Feb 9.
7
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations.由于两个新的PEPD突变导致脯氨酰肽酶缺乏症患者造血干细胞移植后生化参数的部分改善
JIMD Rep. 2012;3:71-7. doi: 10.1007/8904_2011_62. Epub 2011 Sep 27.
8
Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins.脯氨酰肽酶缺乏症,一种罕见的先天性免疫缺陷病,双胞胎的临床表型、免疫学特征及建议的治疗方法。
Allergy Asthma Clin Immunol. 2022 Feb 23;18(1):17. doi: 10.1186/s13223-022-00658-2.
9
Establishment of a human induced pluripotent stem cell line, KMUGMCi007-A, from a patient with prolidase deficiency (PD) bearing homozygous in-frame mutation in the PEPD gene.建立一株人诱导多能干细胞系,KMUGMCi007-A,来源于一名患有脯氨酰内肽酶(PEPD)基因纯合框内突变的原氨酸缺陷症(PD)患者。
Stem Cell Res. 2023 Jun;69:103075. doi: 10.1016/j.scr.2023.103075. Epub 2023 Mar 21.
10
Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series.氨肽酶缺乏症患者的慢性肝病:病例系列
Case Rep Gastroenterol. 2024 Feb 1;18(1):49-57. doi: 10.1159/000536117. eCollection 2024 Jan-Dec.

引用本文的文献

1
A decade of whole-exome sequencing in Brazilian Neurology: from past insights to future perspectives.巴西神经病学领域十年全外显子组测序:从过去的见解到未来的展望
Arq Neuropsiquiatr. 2025 Apr;83(4):1-14. doi: 10.1055/s-0045-1807715. Epub 2025 May 13.
2
Further Clinical Delineation of Prolidase Deficiency Associated with c.1103T>G Variant.与c.1103T>G变异相关的脯氨酰肽酶缺乏症的进一步临床描述
Mol Syndromol. 2024 Aug;15(4):289-296. doi: 10.1159/000536434. Epub 2024 Feb 16.
3
Multiorgan Failure and Sepsis in an ICU Patient with Prolidase Enzyme Deficiency-The Specificity of Treatment and Care: A Case Report.

本文引用的文献

1
Prolidase - A protein with many faces.脯肽酶 - 一张多面的蛋白。
Biochimie. 2021 Apr;183:3-12. doi: 10.1016/j.biochi.2020.09.017. Epub 2020 Oct 10.
2
Co-expression with chaperones can affect protein 3D structure as exemplified by loss-of-function variants of human prolidase.与伴侣分子共表达会影响蛋白质的 3D 结构,人类脯氨酰肽酶的失活变异体就是一个例子。
FEBS Lett. 2020 Sep;594(18):3045-3056. doi: 10.1002/1873-3468.13877. Epub 2020 Jul 14.
3
Clinical Genetics of Prolidase Deficiency: An Updated Review.脯氨酰寡肽酶缺乏症的临床遗传学:最新综述
多器官衰竭和脓毒症在 ICU 患者中 Prolidase 酶缺乏症的特异性治疗和护理:一例报告。
Medicina (Kaunas). 2024 Jun 20;60(6):1006. doi: 10.3390/medicina60061006.
4
A novel PRRX1 loss-of-function variation contributing to familial atrial fibrillation and congenital patent ductus arteriosus.一种导致家族性心房颤动和先天性动脉导管未闭的新型PRRX1功能丧失变异。
Genet Mol Biol. 2022 Mar 30;45(2):e20210378. doi: 10.1590/1678-4685-GMB-2021-0378. eCollection 2022.
Biology (Basel). 2020 May 21;9(5):108. doi: 10.3390/biology9050108.
4
Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult.脯氨酰二肽酶缺乏症:成人合并肺纤维化和肺气肿综合征的一种新的遗传病因。
Eur Respir J. 2020 Apr 9;55(4). doi: 10.1183/13993003.01952-2019. Print 2020 Apr.
5
Prolidase enzyme is required for extracellular matrix integrity and impacts on postnatal cerebellar cortex development.脯氨酰寡肽酶对于细胞外基质的完整性是必需的,并且对出生后小脑皮质的发育有影响。
J Comp Neurol. 2020 Jan 1;528(1):61-80. doi: 10.1002/cne.24735. Epub 2019 Jul 3.
6
CADD: predicting the deleteriousness of variants throughout the human genome.CADD:预测整个人类基因组中变异的有害性。
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894. doi: 10.1093/nar/gky1016.
7
Protein Data Bank: the single global archive for 3D macromolecular structure data.蛋白质数据库:用于存储大分子三维结构数据的全球单一档案库。
Nucleic Acids Res. 2019 Jan 8;47(D1):D520-D528. doi: 10.1093/nar/gky949.
8
Structural basis for prolidase deficiency disease mechanisms.脯肽酶缺乏症发病机制的结构基础。
FEBS J. 2018 Sep;285(18):3422-3441. doi: 10.1111/febs.14620. Epub 2018 Aug 14.
9
ClinVar: improving access to variant interpretations and supporting evidence.ClinVar:改善变异解读和支持证据的获取。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. doi: 10.1093/nar/gkx1153.
10
Substrate specificity and reaction mechanism of human prolidase.人氨肽酶的底物特异性及反应机制
FEBS J. 2017 Sep;284(17):2870-2885. doi: 10.1111/febs.14158. Epub 2017 Aug 8.